Dimensional Fund Advisors
AVBP icon

Dimensional Fund Advisors’s ArriVent BioPharma AVBP Stock Holding History

Dimensional Fund Advisors’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.35M Buy
211,509
+84,984
+67% +$2.51M ﹤0.01% 2428
2026
Q1 		$2.92M Buy
126,525
+111,782
+758% +$2.52M ﹤0.01% 2627
2025
Q4 		$297K Buy
14,743
+585
+4% +$12.2K ﹤0.01% 3045
2025
Q3 		$261K Buy
+14,158
New +$278K ﹤0.01% 3086

Other funds holding AVBP

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors's AVBP Position: Q2 2026 in Review

Dimensional Fund Advisors increased its ArriVent BioPharma (AVBP) stake by 67% in Q2 2026, buying an estimated $2.51M and bringing the position to 211,509 shares worth $7.35M. The position accounts for ﹤0.01% of the portfolio, ranked #2428.

Dimensional Fund Advisors first reported a position in AVBP in Q3 2025 and has held it in 4 quarters since. 157 funds tracked by Wall St. Rank hold AVBP as of Q2 2026.

  • Dimensional Fund Advisors held 211,509 shares of ArriVent BioPharma worth $7.35M as of Q2 2026.
  • Dimensional Fund Advisors bought 84,984 ArriVent BioPharma shares in Q2 2026, an estimated $2.51M.
  • ArriVent BioPharma made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2428 holding.
  • Dimensional Fund Advisors first reported a position in ArriVent BioPharma in Q3 2025 and has held it in 4 quarters since.
  • 157 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.